$LGND - хо ро шо Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.04 by 51.92 percent. This is a 51.92 percent increase over earnings of $1.04 per share from the same period last year. The company reported quarterly sales of $64.83 million which beat the analyst consensus estimate of $55.65 million by 16.50 percent. This is a 54.93 percent increase over sales of $41.85 million the same period last year.